Form 8-K - Current report:
SEC Accession No. 0001104659-23-100775
Filing Date
2023-09-14
Accepted
2023-09-14 16:01:07
Documents
12
Period of Report
2023-09-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326135d1_8k.htm   iXBRL 8-K 27511
  Complete submission text file 0001104659-23-100775.txt   202238

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcel-20230908.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcel-20230908_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcel-20230908_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2326135d1_8k_htm.xml XML 3413
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

EIN.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38935 | Film No.: 231255110
SIC: 2834 Pharmaceutical Preparations